Abstract:Phenylspirodrimanes are a kind of meroterpenoids with structural diversity and complexity, exhibiting a wide of biological properties, especially for the lactam derivatives consisting a γ-lactam moiety and N-linked side chains. These compounds were derived from multi-step combination of enzymatic and non-enzymatic conversions of intermediates in their biosynthetic pathways. Stachbotrydial (2) with an o-phthalaldehyde unit was supposed as the high-reactivity intermediate of phenylspirodrimane lactams via nonenzymatic reaction with amines. In the present work, an effective and non-enzymatic diversification strategy was developed for the structural diversification of phenylspirodrimane lactams including monomers and dimers from 2 by feeding structurally various mono- and diamines in the fungus Stachybotrys chartarum cultures. In total, 24 phenylspirodrimane lactams (1, 3–25) including 18 new compounds were synthesized. Among them, stachybocin A (1), a bioactive phenylspirodrimane lactam dimer, was produced with the yield of 18.7 mg/g of cell dry weight. The structures of these compounds were elucidated by extensive spectroscopic data, single-crystal X-ray diffraction (Cu Kα), and calculated electronic circular dichroism (ECD) analyses. Bioassay revealed that compounds 1, 17, and 24 displayed significant inhibitory effect on the inactivated state of hNaV 1.2 channels with IC50 values of 0.22, 2.08, and 0.53 μmol/L, respectively. In addition, 1 showed potent protein tyrosine phosphatase 1B (PTP1B) inhibitory, N-methyl-D-aspartate (NMDA) receptor antagonistic, and anti-inflammatory activities.

Structural diversification of phenylspirodrimane lactams by employing a biosynthetic intermediate

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

Bistachybotrysins L-V, Bioactive Phenylspirodrimane Dimers from the Fungus Stachybotrys Chartarum

Spirocyclic Drimanes from the Marine Fungus Stachybotrys sp. Strain MF347

Distachydrimanes A-F, phenylspirodrimane dimers and hybrids with cytotoxic activity from the coral-derived fungus Stachybotrys chartarum

A new phenylspirodrimane derivative from the deep-sea-derived fungus Stachybotrys chartarum FS705

New Antifungal Metabolites from the Mariana Trench Sediment-Associated Actinomycete Streptomyces Sp. SY1965

Three New Phenylspirodrimanes from a Conch-Derived Fungus Stachybotrys Sp. NF02434

Phenylspirodrimane with Moderate Reversal Effect of Multidrug Resistance Isolated from the Deep-Sea Fungus Stachybotrys sp. 3A00409

Bioactive Metabolites from Marine-Derived Streptomyces Sp A68 and Its Rifampicin Resistant Mutant Strain R-M1

Novel Stemphol Derivatives from a Marine Fungus Pleospora Sp

Stachybotrysins A-G, Phenylspirodrimane Derivatives from the Fungus Stachybotrys Chartarum.

Phenylspirodrimanes with Anti-Hiv Activity from the Sponge-Derived Fungus Stachybotrys Chartarum MXH-X73.

Synthesis, fungicidal activity, and structure-activity relationship of spiro-compounds containing macrolactam (macrolactone) and thiadiazoline rings.

Enantioselective Total Synthesis and Structure Revision of Spirodihydrobenzofuranlactam 1. Total Synthesis of Stachybotrylactam.

Structurally Diverse Metabolites from the Marine‐Derived Streptomyces sp. DS‐27 Based on Two Different Culture Conditions

Stachybotranes A–D, Phenylspirodrimanes from the Wetland Fungus Stachybotrys Chartarum with Cytotoxic Activities

Chartarlactams A–P, Phenylspirodrimanes from the Sponge-Associated Fungus Stachybotrys Chartarum with Antihyperlipidemic Activities

Total Synthesis and Structure Revision Ofstachybotrysspirolactams

Synthesis and Fungicidal Activity Study of Novel Daphneolone Analogs with 2,6-Dimethylmorpholine

Two new lactam derivatives from a Sphagneticola trilobata derived fungus Penicillium rubens PQJ-2